HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and biological evaluation of the 12,12-dimethyl derivative of Aplog-1, an anti-proliferative analog of tumor-promoting aplysiatoxin.

Abstract
Aplog-1 is a unique analog of tumor-promoting aplysiatoxin that inhibits tumor-promotion by phorbol diesters and proliferation of tumor cells. While the structural features relevant to the biological activities of Aplog-1 remain to be identified, recent studies by us have suggested that local hydrophobicity around the spiroketal moiety of Aplog-1 is a crucial determinant of its anti-proliferative activity. This hypothesis led us to design 12,12-dimethyl-Aplog-1 (3), in which a hydrophobic geminal dimethyl group is installed proximal to the spiroketal moiety to improve biological potency. As expected, 3 was more effective than Aplog-1 in inhibiting cancer cell growth and binding to protein kinase Cδ, a putative receptor responsible for the biological response of Aplog-1. Moreover, an induction test on Epstein-Barr virus early antigen demonstrated 3 to be a better anti-tumor promoter than Aplog-1. These results indicate that 3 is a superior derivative of Aplog-1, and thus a more promising lead for anti-cancer drugs.
AuthorsYu Nakagawa, Masayuki Kikumori, Ryo C Yanagita, Akira Murakami, Harukuni Tokuda, Hiroshi Nagai, Kazuhiro Irie
JournalBioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem) Vol. 75 Issue 6 Pg. 1167-73 ( 2011) ISSN: 1347-6947 [Electronic] England
PMID21670518 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticarcinogenic Agents
  • Antigens, Viral
  • Carcinogens
  • Epstein-Barr virus early antigen
  • Furans
  • Lyngbya Toxins
  • Phorbol Esters
  • Spiro Compounds
  • spiroketal
  • aplysiatoxin
  • Protein Kinase C-delta
Topics
  • Anticarcinogenic Agents (chemical synthesis, pharmacology)
  • Antigens, Viral (analysis, biosynthesis)
  • B-Lymphocytes (pathology, virology)
  • Carcinogens (antagonists & inhibitors, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Dose-Response Relationship, Drug
  • Epstein-Barr Virus Infections (drug therapy, pathology, prevention & control)
  • Furans (chemical synthesis, pharmacology)
  • Herpesvirus 4, Human (drug effects, physiology)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Lyngbya Toxins (adverse effects, pharmacology)
  • Methylation
  • Neoplasms (drug therapy, pathology, prevention & control)
  • Phorbol Esters (adverse effects, pharmacology)
  • Protein Binding
  • Protein Kinase C-delta (antagonists & inhibitors, metabolism)
  • Spiro Compounds (chemical synthesis, pharmacology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: